ECSP045108A - SOLID FORMULATION TO USE AS A MEDICINAL BASED ON A PIPERAZINUREA DERIVATIVE - Google Patents

SOLID FORMULATION TO USE AS A MEDICINAL BASED ON A PIPERAZINUREA DERIVATIVE

Info

Publication number
ECSP045108A
ECSP045108A EC2004005108A ECSP045108A ECSP045108A EC SP045108 A ECSP045108 A EC SP045108A EC 2004005108 A EC2004005108 A EC 2004005108A EC SP045108 A ECSP045108 A EC SP045108A EC SP045108 A ECSP045108 A EC SP045108A
Authority
EC
Ecuador
Prior art keywords
piperazinurea
derivative
solid formulation
medicinal
medicinal based
Prior art date
Application number
EC2004005108A
Other languages
Spanish (es)
Inventor
Heiko Kranz
Christoph Voelkel
Ralph Lipp
Johannes Tack
Herbert Wiesinger
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ECSP045108A publication Critical patent/ECSP045108A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

La invención se refiere a una formulación sólida para utilizar como medicamento que contiene (2R)-1-((4-cloro-2-(ureido)fenoxi) metil)carbonil-2- metil-4-(4-fluoro- bencil)-piperazina o una de sus salesThe invention relates to a solid formulation for use as a medicament containing (2R) -1 - ((4-chloro-2- (ureido) phenoxy) methyl) carbonyl-2- methyl-4- (4-fluorobenzyl) -piperazine or one of its salts

EC2004005108A 2001-10-18 2004-05-17 SOLID FORMULATION TO USE AS A MEDICINAL BASED ON A PIPERAZINUREA DERIVATIVE ECSP045108A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10152351A DE10152351B4 (en) 2001-10-18 2001-10-18 Solid drug formulation for a piperazine urea derivative

Publications (1)

Publication Number Publication Date
ECSP045108A true ECSP045108A (en) 2004-06-28

Family

ID=7703496

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005108A ECSP045108A (en) 2001-10-18 2004-05-17 SOLID FORMULATION TO USE AS A MEDICINAL BASED ON A PIPERAZINUREA DERIVATIVE

Country Status (23)

Country Link
EP (1) EP1435917A1 (en)
JP (1) JP2005506365A (en)
KR (1) KR20040047920A (en)
CN (1) CN1571660A (en)
AR (1) AR037111A1 (en)
AU (1) AU2002333896B2 (en)
BR (1) BR0213340A (en)
CA (1) CA2463951A1 (en)
CO (1) CO5580740A2 (en)
DE (1) DE10152351B4 (en)
EC (1) ECSP045108A (en)
HR (1) HRP20040435A2 (en)
IL (1) IL161166A0 (en)
MX (1) MXPA04003522A (en)
NO (1) NO20042022L (en)
NZ (1) NZ532287A (en)
PE (1) PE20030472A1 (en)
PL (1) PL367987A1 (en)
RS (1) RS32204A (en)
RU (1) RU2311172C2 (en)
UY (1) UY27500A1 (en)
WO (1) WO2003035037A1 (en)
ZA (1) ZA200403781B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE374181T1 (en) 2001-06-27 2007-10-15 Smithkline Beecham Corp FLUORPYRROLIDINES AS DIPEPTIDYLPEPTIDASE INHIBITORS
EP1749519A1 (en) 2005-08-05 2007-02-07 Schering Aktiengesellschaft Dosage form with pH-independent sustained release for active substances with pH-dependent solubility
NZ703464A (en) * 2006-04-26 2016-05-27 Alphapharm Pty Ltd Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
DE102008047910A1 (en) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tabletting excipient based on lactose and cellulose
KR101654582B1 (en) 2016-05-12 2016-09-06 그린로드(주) Conical Shaped Buoyant Polymer Filter and Apparatus for Manufacturing the same and Method for Manufacturing the same and Water Treatment Filter including the same
RU2729223C1 (en) * 2020-05-13 2020-08-05 Мераб Георгиевич Чикобава Dosage form for amplification of nucleic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207665B1 (en) * 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
EA003137B1 (en) * 1998-02-05 2003-02-27 Пфайзер Продактс Инк Novel dihydroxyhexanoic acid derivatives
EP1027885B1 (en) * 1999-02-09 2008-07-09 Pfizer Products Inc. Basic drug compositions with enhanced bioavailability

Also Published As

Publication number Publication date
UY27500A1 (en) 2003-06-30
AR037111A1 (en) 2004-10-20
WO2003035037A1 (en) 2003-05-01
CO5580740A2 (en) 2005-11-30
MXPA04003522A (en) 2004-07-23
DE10152351A1 (en) 2003-05-08
RS32204A (en) 2006-10-27
CN1571660A (en) 2005-01-26
AU2002333896B2 (en) 2007-07-26
EP1435917A1 (en) 2004-07-14
JP2005506365A (en) 2005-03-03
AU2002333896A2 (en) 2003-05-06
RU2311172C2 (en) 2007-11-27
RU2004115328A (en) 2005-06-10
CA2463951A1 (en) 2003-05-01
NO20042022L (en) 2004-05-14
PE20030472A1 (en) 2003-06-16
NZ532287A (en) 2007-04-27
DE10152351B4 (en) 2005-09-22
HRP20040435A2 (en) 2005-06-30
ZA200403781B (en) 2004-11-29
IL161166A0 (en) 2004-08-31
KR20040047920A (en) 2004-06-05
PL367987A1 (en) 2005-03-21
BR0213340A (en) 2004-10-05

Similar Documents

Publication Publication Date Title
UY28342A1 (en) NEW COMPOUNDS
CL2009001279A1 (en) Nociceptin derived compounds; pharmaceutical composition comprising said compound; and use of the compound for the treatment of pain (sol. divisional 2103-03).
UY28348A1 (en) NEW COMPOUNDS
PA8518801A1 (en) DERIVATIVES OF 2-AMINOCARBONIL-9H-PURINA
HN2002000300A (en) NEW DERIVATIVES OF PIPERAZINA
ECSP034774A (en) PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS
ECSP034773A (en) PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS
HN2003000408A (en) NEW DERIVATIVES OF HETEROCICLIC FLUOROGLYCOSIDES, MEDICINES CONTAINING THESE COMPOUNDS, AND THE USE OF THE SAME.
HN2003000407A (en) NEW DERIVATIVES OF AROMATIC FLUOROGLYCOSISES, MEDICINES CONTAINING THESE COMPOUNDS AND THEIR USES.
ECSP066365A (en) ANILINO PURINAS REPLACED IN POSITION 6 USEFUL AS RTK INHIBITORS
SV2008001369A (en) BENZIMIDAZOLES
BR9909565A (en) Bicyclic derivatives of hydroxamic acid
PA8570901A1 (en) DERIVATIVES OF ACIL-4-CARBOXIFENILUREA, PROCEDURES FOR PREPARATION AND USE
PA8582801A1 (en) NEW SPIROTRICYCLIC DERIVATIVES AND THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE
CR8178A (en) EMULSION SYSTEMS CONTAINING DERIVATIVES OF AZETIDINE
AR045572A1 (en) A COMBINATION THAT INCLUDES N- (3-METOXI-5-METHYLPIRAZIN-2-IL) -2- (4- [1,3,4-OXADIAZOL-2-IL] PHENYL-3-SULFONAMIDE AND AN ANALOG LHRH AND / OR A bisphosphonate
ES2421948T3 (en) Compounds and compositions for delivering active agents
CY1110130T1 (en) MORPHOLINE PRODUCTS FOR USE AS DOPAMINE AGONISTS IN THERAPEUTIC DISEASE Therapeutic Treatment I.A.
ECSP045493A (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLIBANSERINE POLYMORPH A
PA8586801A1 (en) HIV-INTEGRESS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE
AR041340A1 (en) DERIVATIVES OF THIAZOLPIRIMIDINONE, PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR058047A1 (en) ADMINISTRATION OF DIPEPTIDIL PEPTIDASA INHIBITORS
ECSP045108A (en) SOLID FORMULATION TO USE AS A MEDICINAL BASED ON A PIPERAZINUREA DERIVATIVE
UY27610A1 (en) COMBINATION OF PTM INHIBITORS OR INHIBITORS OF THE APOB SECRETION WITH FIBRATES FOR USE AS MEDICATIONS
ES2189072T3 (en) NEW BENZO-HETEROCICLIC CYCLALKINS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.